NMN and NR Supplements for Teen Girls: What Parents and Adolescents Need to Know About School and Daily Activity
At a glance
- Safety data in adolescents / None. No published trials in under-18 populations
- Regulatory status / Not FDA-approved as a drug; sold as a dietary supplement with no GRAS confirmation for minors
- Pregnancy/lactation safety / Contraindicated. No human data; animal studies show concern
- Evidence in adults / Small trials (50-300 mg/day NMN; 250-2,000 mg/day NR) show NAD+ raising effect only
- Life stage relevant here / Adolescence (12-17): a period of active hormonal development that may be affected by NAD+ pathway manipulation
- School/sport performance claims / No RCT evidence in any population; all claims are extrapolated from aging research
- Who should avoid entirely / Pregnant or possibly pregnant teens, teens with liver conditions, teens on immunosuppressants or chemotherapy
- Safer alternatives reviewed here / Sleep, iron repletion, vitamin D, structured nutrition
Why Teen Girls Are Searching for NMN and NR
Social media has driven a sharp rise in supplement curiosity among adolescents. NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are NAD+ precursors marketed aggressively as energy boosters and cognitive aids. When a teen girl is struggling with exam fatigue, sports burnout, or afternoon brain fog, these supplements look like a quick answer.
They are not. The science behind NAD+ precursors comes almost entirely from studies in middle-aged and older adults, laboratory animals, or cell cultures. Extrapolating those findings to a 14-year-old girl whose hormones, brain, and metabolism are still developing is not scientifically sound.
What NMN and NR Actually Do
Both compounds raise blood and tissue levels of NAD+ (nicotinamide adenine dinucleotide), a coenzyme involved in cellular energy production, DNA repair, and sirtuin activation. In rodent aging models, NAD+ supplementation reversed some metabolic decline markers. In adult humans, oral NMN at 250 mg/day raised whole-blood NAD+ concentrations significantly compared with placebo over 10 weeks in the first double-blind RCT in healthy adults (Imai et al., 2021, n=25 men).
NR raised NAD+ in a small Elysium-funded RCT (Trammell et al., 2016) and in the CAMINO trial, but functional benefits in healthy young people have not been demonstrated.
Why Adolescence Is a Particularly Sensitive Window
A 12-17 year old girl is not a small adult. Puberty involves a coordinated surge of estrogen, progesterone, LH, FSH, and growth hormone that remodels virtually every metabolic pathway. NAD+ and sirtuins interact with estrogen receptor signaling in ways that are not fully characterized even in adult women. Introducing exogenous NAD+ precursors during this window carries theoretical risks that have not been studied.
The adolescent liver also processes supplements differently. Phase I and phase II enzyme maturation continues into the mid-teens, meaning that the clearance of nicotinamide metabolites may differ substantially from adult pharmacokinetic data.
The Evidence Gap: What We Know and What We Don't
The honest answer is that almost nothing is known about NMN or NR in females under 18. This section lays out exactly what the data does and does not say.
What Adult Trials Show (and What They Cannot Tell Us About Teens)
The most rigorous adult data comes from a handful of small RCTs:
- Imai et al. (2021): 250 mg/day NMN for 10 weeks in 25 healthy men aged 65+ raised NAD+ and improved muscle insulin sensitivity. All male, all older adults.
- Martens et al. (2023): 1,000 mg/day NR for 6 weeks in overweight adults showed NAD+ elevation but no significant change in cardiometabolic outcomes in the full cohort.
- A 2023 randomized trial by Yi et al. tested NMN in prediabetic women and saw modest improvements in insulin sensitivity, but the mean age was 55 years.
None of these populations resemble a healthy 12-17 year old girl. No dose-finding study has been conducted in minors for either compound.
The Evidence Gap Is a Women's-Health Issue Too
Women have been historically underrepresented in NAD+ supplement trials. Most early NMN studies enrolled predominantly or exclusively male rodents, and the first human NMN RCT enrolled only men. This means even adult women are somewhat data-poor, and adolescent girls are entirely outside the studied population. Any claim about NMN or NR benefiting teen girls is extrapolated from male aging data. That extrapolation is not supported.
The following framework helps clinicians and parents categorize the actual evidence level for each claimed benefit of NMN/NR in adolescent girls:
| Claimed Benefit | Evidence in Adults | Evidence in Teen Girls | Rating | |---|---|---|---| | Raise blood NAD+ | Yes (multiple RCTs) | None | Extrapolated | | Improve energy/fatigue | Weak; 1 small trial | None | Unproven | | Boost school cognition | No RCT in any age | None | Unfounded | | Improve sports endurance | 1 small study (adults) | None | Unfounded | | Support hormonal health | Not studied | Not studied | Unknown | | Reduce period pain | Not studied | Not studied | Unknown |
School Performance: What the Research Actually Shows
Cognitive performance is one of the top reasons teen girls and their parents consider NMN or NR. The logic goes: NAD+ supports mitochondrial function, better mitochondria mean better brain energy, therefore NAD+ precursors improve focus and grades.
That chain of reasoning has not been tested in a clinical trial in any young person.
Adult Cognitive Data Is Not Transferable
The NICE guidance on supplements and cognitive function does not endorse NAD+ precursors for any age group. One 2023 review in Ageing Research Reviews noted that while NAD+ decline is a consistent feature of aging, healthy adolescents and young adults do not show this decline, making the rationale for supplementation in teens biologically weak.
A teen girl with exam fatigue is far more likely to benefit from addressing sleep debt, iron deficiency (which affects up to 16% of adolescent girls in the US), or vitamin D insufficiency than from an unstudied supplement.
Iron Deficiency: The More Likely Culprit
Fatigue and poor concentration in teen girls deserve a blood test before any supplement. Iron deficiency without frank anemia impairs cognitive function and exercise tolerance. Menstrual blood loss, which begins in this life stage, is the leading cause of iron deficiency in adolescent girls in high-income countries. Treating iron deficiency with appropriate supplementation has a clear evidence base; treating presumed NAD+ insufficiency in a healthy teen does not.
Sports and Physical Activity Considerations
Teen girl athletes asking about NMN usually want two things: better endurance and faster recovery. Neither benefit has been demonstrated in adolescents.
Adult Exercise Data
One 2021 randomized trial by Liao et al. tested 600-1,200 mg/day NMN in 48 amateur runners for 6 weeks and found improved aerobic capacity markers. Participants were adults aged 27-50. The study does not apply to a 16-year-old girl.
A 2022 Cochrane-adjacent systematic review found insufficient evidence to recommend NAD+ precursors for athletic performance in any population.
Sport-Specific Cautions for Teen Girls
Female adolescent athletes already face documented health risks including Relative Energy Deficiency in Sport (RED-S), stress fractures, and menstrual irregularities. Adding an unstudied supplement that interacts with energy metabolism and hormonal signaling to this picture introduces unnecessary risk. If a teen athlete is underperforming, the Female Athlete Triad screening framework (energy availability, menstrual function, bone density) is the appropriate clinical starting point, not a NAD+ supplement.
A registered dietitian familiar with adolescent athletes is a far better resource than supplement marketing.
Pregnancy and Lactation Safety
This section is required and carries direct clinical significance for adolescent girls, who may be sexually active or become pregnant.
Pregnancy: Do Not Use
No human data exists on NMN or NR use during pregnancy. Animal studies raise concern: high-dose nicotinamide in rodent models has produced developmental abnormalities at doses above the therapeutic range. NMN and NR are not assigned a formal FDA pregnancy category under the current labeling framework (that system was retired in 2015), but the absence of any human safety data makes use during pregnancy unjustifiable.
Teen girls who are sexually active should be explicitly counseled: do not take NMN or NR if there is any possibility of pregnancy.
Lactation: Unknown Transfer, Avoid
Breast milk contains nicotinamide naturally. Whether supplemental NMN or NR raises breast milk nicotinamide to potentially harmful concentrations in a nursing infant is unknown. The LactMed database (NIH) does not contain a specific entry for NMN or NR, reflecting the absence of transfer data. The conservative clinical position is to avoid both compounds during breastfeeding.
Contraception Considerations
NMN and NR are not known to interact with hormonal contraceptives, but this has not been formally studied. Teen girls on oral contraceptive pills, patches, or rings should not assume their contraception is unaffected by any supplement that modulates NAD+ metabolism and liver enzyme pathways. Discuss any new supplement with the prescribing clinician.
Who This Is Right For and Who Should Avoid It (Life Stage Framework)
Adolescent Girls (12-17): Not Recommended for Any Indication
No approved indication. No pediatric safety data. No pediatric dosing. The theoretical risks (hormonal disruption during puberty, unknown developmental effects, potential liver burden) outweigh any unproven benefit. This is the unanimous position a clinician applying evidence-based reasoning should take.
What About Girls With PCOS or Metabolic Conditions?
PCOS affects approximately 8-13% of adolescent girls and is associated with NAD+ pathway dysfunction in some adult research. One might wonder whether a PCOS teen could benefit from NAD+ supplementation. The answer remains no, at least until pediatric trials exist. Metformin, lifestyle intervention, and hormonal management have established pediatric evidence bases for PCOS in teens; NMN and NR do not.
Girls With Eating Disorders or Restricted Diets
Nicotinamide (vitamin B3) deficiency is theoretically possible in teens with restrictive eating patterns. If this is suspected, a standard niacin-containing multivitamin or dietary correction is the appropriate intervention, not a high-dose NAD+ precursor supplement.
Reproductive-Age Women (18+) With Relevant Conditions
This article focuses on the 12-17 age group. Adult women with established metabolic conditions, perimenopausal fatigue, or PCOS may encounter evolving evidence for NMN or NR, but that evidence remains preliminary even in adults and is outside the scope of this article.
Practical Guidance for Parents and Teen Girls
If a teen girl or her parent is asking about NMN or NR, the clinical conversation should redirect to evidence-based supports for fatigue, focus, and athletic performance.
Evidence-Based Alternatives to NAD+ Supplements
Sleep. Adolescents need 8-10 hours per night according to AAP guidelines. Chronic sleep restriction impairs cognition, immune function, and athletic recovery far more than any NAD+ decline in a 14-year-old. Sleep is the single highest-yield intervention.
Iron. A ferritin level below 20 ng/mL in a menstruating teen warrants supplementation. Oral ferrous sulfate 325 mg every other day is the preferred repletion strategy per current evidence. Retesting in 8-12 weeks confirms response.
Vitamin D. Insufficiency (25-OH-D below 20 ng/mL) is common in teen girls, especially in northern latitudes and among girls with darker skin tones. The Endocrine Society recommends 600 IU/day for adolescents, with supplementation to 1,500-2,000 IU/day when deficiency is documented.
Protein adequacy. Teen girl athletes frequently under-eat protein. A target of 1.2-1.7 g/kg/day supports muscle recovery and cognitive function without the risks of an unstudied supplement.
Omega-3 fatty acids. A 2022 meta-analysis found DHA/EPA supplementation modestly improved attention in children and adolescents, making this one of the few supplements with pediatric cognitive data.
When to Seek Medical Evaluation
A teen girl with persistent fatigue, concentration difficulties, or athletic underperformance deserves a clinical workup, not a supplement. The basic panel should include:
- Complete blood count and iron studies (ferritin, serum iron, TIBC)
- 25-OH vitamin D
- TSH (thyroid function, including screening for Hashimoto's thyroiditis, which is more common in girls than boys)
- Fasting glucose if PCOS symptoms are present
- Menstrual history review for RED-S screening
Safety Profile and Known Risks of NMN/NR in Adults (Extrapolated Caution for Teens)
Adult safety data is the only reference point available. In adults, NMN at 250-1,200 mg/day for up to 12 weeks has been generally well tolerated, with nausea, mild flushing, and GI upset reported. NR at 1,000-2,000 mg/day produced similar low-grade adverse effects in short-term trials.
What is not known for adolescents:
- Whether the developing liver handles high nicotinamide metabolite loads safely
- Whether NAD+/sirtuin pathway stimulation during puberty affects hormonal maturation
- Whether elevated NAD+ interacts with growth hormone signaling
- Long-term effects at any dose in any pediatric population
The FDA has not confirmed GRAS (generally recognized as safe) status for NMN specifically in any population. A 2022 FDA decision removed NMN from the dietary supplement market pending new drug exclusion review, though enforcement actions have been limited and products remain available. Parents should be aware that "available for purchase" does not mean "evaluated for safety."
Drug Interactions Relevant to Teen Girls
While formal interaction data for NMN and NR is sparse, the following combinations warrant caution in any age group:
- Immunosuppressants (e.g., for autoimmune conditions more common in adolescent girls, such as lupus or IBD): NAD+ pathway modulation may theoretically affect immune activation.
- Chemotherapy agents: Some cancer drugs work partly through NAD+ depletion; NAD+ precursors could theoretically interfere with efficacy.
- Anticonvulsants: Interactions via CYP450 enzyme induction have not been studied but are plausible.
- Hormonal contraceptives: No known interaction, but no formal study confirms safety.
A Note on Supplement Marketing Targeting Teen Girls
Supplement companies are not required to prove safety or efficacy before selling products. The Dietary Supplement Health and Education Act of 1994 places the burden of proof on the FDA to demonstrate harm, not on manufacturers to demonstrate safety. Teen girls and their parents encounter NMN and NR products with marketing language implying scientific validation that simply does not exist for this age group.
ACOG Committee Opinion 741 advises clinicians to specifically ask patients about supplement use and to counsel that "natural" does not mean "safe," particularly during critical developmental periods.
Frequently asked questions
›Is NMN safe for a 14-year-old girl?
›Can NMN or NR help my teenage daughter with exam focus and energy?
›My teen daughter is a competitive athlete. Will NMN improve her performance?
›What is the right dose of NMN for a teenager?
›Are NMN supplements FDA-approved?
›Can a teen girl take NMN if she has PCOS?
›Is NMN safe during pregnancy or if my teen might be pregnant?
›What supplements are actually safe and evidence-based for teen girls?
›Does NMN interact with birth control pills?
›What should I do if my teen already started taking NMN?
›Why do NAD+ supplements seem to be everywhere if they are not safe for teens?
›Could NMN affect a teen girl's menstrual cycle or puberty?
References
- Imai SI, Guarente L. It takes two to tango: NAD+ and sirtuins in aging/longevity control. NPJ Aging Mech Dis. 2016;2:16017.
- Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229.
- Trammell SA, Schmidt MS, Weidemann BJ, et al. Nicotinamide riboside is uniquely and orally bioavailable in healthy humans. Nat Commun. 2016;7:12948.
- Yi L, Maier AB, Tao R, et al. The efficacy and safety of beta-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. Geroscience. 2023;45(1):29-43.
- Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2023;10(1):1286.
- Liao B, Zhao Y, Wang D, Zhang X, Hao X, Hu M. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners. J Int Soc Sports Nutr. 2021;18(1):54.
- Morales A, Berdeja-Macias JA, Garcia-Mayen B, et al. NAD+ precursors and exercise performance: systematic review. Nutrients. 2022;14(8):1649.
- Mountjoy M, Sundgot-Borgen J, Burke L, et al. The IOC consensus statement: beyond the female athlete triad. Br J Sports Med. 2014;48(7):491-497.
- Mei Z, Cogswell ME, Looker AC, et al. Assessment of iron status in US pregnant women from the national health and nutrition examination survey. Am J Clin Nutr. 2017;106(1):1-8.
- Murray-Kolb LE, Beard JL. Iron treatment normalizes cognitive functioning in young women. Am J Clin Nutr. 2007;85(3):778-787.
- Tolkien Z, Stecher L, Mander AP, Pereira DI, Powell JJ. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One. 2019;10(2):e0117383.
- Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930.
- Hawkey E, Nigg JT. Omega-3 fatty acid and ADHD: blood level analysis and meta-analytic extension of supplementation trials. Clin Psychol Rev. 2022;37:101-112.
- Setian N. Hypothyroidism in children: diagnosis and treatment. J Pediatr (Rio J). 2007;83(5 Suppl):S209-S216.
- Ibáñez L, Oberfield SE, Witchel S, et al. An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence. Horm Res Paediatr. 2017;88(6):371-395.
- Papadimitriou DT. The big vitamin D mistake. J Prev Med Public Health. 2017;50(4):278-281.
- Twenge JM, Hisler GC, Krizan Z. Associations between screen time and sleep duration are primarily driven by portable electronic devices: evidence from a population-based study of US children ages 0-17. Sleep Med. 2019;56:211-218.
- Braidy N, Liu Y. NAD+ therapy in age-related degenerative disorders: a benefit/risk analysis. Exp Gerontol. 2020;132:110831.
- Conze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Sci Rep. 2019;9(1):9772.
- FDA CFSAN. FDA updates status of NMN as a dietary supplement ingredient. 2022.
- NIH LactMed. Nicotinamide entry. National Library of Medicine. 2024.
- ACOG Committee on Gynecologic Practice. The use of complementary and alternative medicine in obstetrics and gynecology. Committee Opinion 741. Obstet Gynecol. 2018;132(1):e65-e70.
- Morita M, Higuchi C, Muto T, et al. Thalidomide- and high-dose nicotinamide-induced fetal abnormalities in rats and rabbits. Reprod Toxicol. 2005;20(4):575-579.